MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.dld.2025.10.029

Медицинская библиотека · Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2025

Do all presumed BD-IPMNs require lifelong surveillance? Clinical outcomes and implications of guidelines-based discontinuation.

Terrin Maria, Spadaccini Marco, Poletti Valeria, De Palma Cataldo, Mercurio Miriana, Minini Francesco, Spertino Matteo, Colombo Matteo, Andreozzi Marta, Bonifacio Cristiana, Capretti Giovanni, Rossi Roberta Elisa, Fugazza Alessandro, Hassan Cesare, Repici Alessandro, Zerbi Alessandro, Carrara Silvia

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Management of presumed branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) without worrisome features (WF) or high-risk stigmata (HRS) remains controversial, particularly regarding the duration of surveillance.

METHODS

We conducted a retrospective single-center study including patients with presumed BD-IPMNs without WF or HRS at diagnosis, followed between 2014 and 2023. Clinical, radiological, and pathological data were collected. Outcomes included malignant progression, surgery, and mortality. Subgroup analyses assessed patients with ≥5years of follow-up, potentially meeting discontinuation criteria.

RESULTS

413 patients met inclusion criteria. Median age at diagnosis was 65 years; 64 % were women. Median cyst size was 10 mm, and median follow-up 36 months. WF developed in 20 % of patients and HRS in 0.7 %. Four patients (0.26/100 person-years) experienced malignant progression, all within 30 months from diagnosis; two underwent surgery, revealing adenocarcinoma in both. In 108 patients followed ≥5 years, 89 remained stable. None developed cancer, required surgery, or died from BD-IPMN. Seven developed WF after 5 years. Depending on criteria, 49 % according to Marchegiani and 63 % according to Kyoto would qualify for discontinuation of surveillance.

CONCLUSIONS

In real-world practice, malignant progression of presumed BD-IPMNs without WF/HRS is rare and tends to occur early. After 5 years of stability, surveillance discontinuation may be safe in selected subgroups, although prospective validation is needed.

Для цитирования: Terrin Maria, Spadaccini Marco, Poletti Valeria, De Palma Cataldo, Mercurio Miriana, Minini Francesco, Spertino Matteo, Colombo Matteo, Andreozzi Marta, Bonifacio Cristiana, Capretti Giovanni, Rossi Roberta Elisa, Fugazza Alessandro, Hassan Cesare, Repici Alessandro, Zerbi Alessandro, Carrara Silvia. Do all presumed BD-IPMNs require lifelong surveillance? Clinical outcomes and implications of guidelines-based discontinuation.. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2025. DOI: 10.1016/j.dld.2025.10.029.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.